Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
#Events

Category: Uncategorized

Accelerating the Onshoring Wave: FDA Enrolls Eli Lilly and Regeneron in Landmark Real-Time Construction Review Pilot

30/06/2026 Published by Pharma Biz

Key Development The U.S. Food and Drug Administration (FDA) has officially announced the selection of seven pioneering pharmaceutical and biotechnology... Read more

Tags: #Global Trends

Institutional Capital Hedging via Royalty Consolidation: Analyzing Zymeworks’ $929 Million Takeover of Theravance

30/06/2026 Published by Pharma Biz

Key Development Global oncology therapeutics specialist Zymeworks (Vancouver, Canada) has entered into a definitive merger agreement to acquire the distressed... Read more

Category: Uncategorized

Tags: #M&A

The $4 Billion VMS Bidding War: Unilever and Haleon Counter-Bid for L Catterton’s High-Growth Asset, Thorne

30/06/2026 Published by Pharma Biz

Key Development The global consumer health and wellness ecosystem has transformed into a high-stakes corporate battlefield as fast-moving consumer goods... Read more

Category: Uncategorized

Tags: #M&A

Quality Risk Governance: Analyzing Amgen’s Nationwide Recall of 1 Million Corlanor and Sensipar Bottles in the U.S.

30/06/2026 Published by Pharma Biz

Key Development Global biopharmaceutical leader Amgen has initiated a voluntary nationwide recall encompassing at least 944,142 bottles of its chronic... Read more

Category: Uncategorized

Tags: #Global Trends

Dominating the Chronic Care Matrix: Analyzing Viatris’ 5-Year Journey and Strategic Originator Localization in Vietnam

30/06/2026 Published by Pharma Biz

Key Development Global healthcare aggregator Viatris (Nasdaq: VTRS) has successfully concluded a high-profile national scientific symposium series titled "Non-Communicable Diseases... Read more

Category: Uncategorized

Tags: #Vietnam

Late-Stage Asset Crystallization: Analyzing Ipsen’s $1.7 Billion Strategic Acquisition of Kartos Therapeutics

29/06/2026 Published by Pharma Biz

Key Development Global biopharmaceutical leader Ipsen (Euronext: IPN; ADR: IPSEY) has formally entered into a definitive merger agreement to acquire... Read more

Category: Uncategorized

Tags: #M&A

Chemistry, Manufacturing, and Controls Bottlenecks: Analyzing the FDA’s Complete Response Letter for Sobi’s Gout Biologic

29/06/2026 Published by Pharma Biz

Key Development Global specialized biopharmaceutical leader Swedish Orphan Biovitrum AB (Sobi) has officially announced the receipt of a Complete Response... Read more

Category: Uncategorized

Tags: #Global Trends

Reversing Corporate Criminal Exposure: US DOJ Closes Criminal Investigation into Abbott Over Baby Formula Plant Missteps

29/06/2026 Published by Pharma Biz

Key Development The U.S. Department of Justice (DOJ) has officially closed its multi-year criminal investigation into healthcare giant Abbott Laboratories... Read more

Category: Uncategorized

Tags: #Global Trends

Clinical Data Integrity Collapses: Analyzing EMA’s Recommendation to Revoke Amgen’s Orphan Drug Authorization for Tavneos

29/06/2026 Published by Pharma Biz

Key Development The European Medicines Agency (EMA) has formally issued a negative regulatory recommendation, calling for the revocation of the... Read more

Category: Uncategorized

Tags: #Global Trends

Posts pagination

Previous page Page 1 … Page 40 Page 41 Page 42 … Page 200 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members